Expression of the chondroitin sulphate proteoglycan, NG2, in paediatric brain tumors

Samantha Higgins, Anna J. Boltheus, Laura Donovan, Harutomo Hasegawa, Lawrence Doey, Safa Al Sarraj, Keyoumars Ashkan, Federico Roncaroli, Helen Fillmore, Geoff Pilkington

Research output: Contribution to journalArticlepeer-review

50 Downloads (Pure)


Background/Aim: While neuron-glia 2 (NG2) is well-characterized in the developing brain and in adult high-grade gliomas, little is known about NG2 expression in paediatric brain tumors. Here, NG2 expression was examined in a range of paediatric brain tumors.

Materials and Methods
: A retrospective immunohistopathological analysis of 57 paediatric brain tumor biopsies of various tumor types was carried out. Paediatric cell lines, including two medulloblastomas and one dysembryoplastic neuroepithelial tumor, in addition to one adult high-grade glioma, were also assessed for NG2 expression.

: NG2-positive staining was seen in all dysembryoplastic neuroepithelial tumors (DNETs) examined; however, only two of the fourteen medulloblastomas examined were NG2-positive. Compared to adult glioma, there was a lack of NG2 staining in the vasculature of paediatric brain tumors.

Conclusion: NG2 expression in paediatric brain tumors differs depending upon type and, unlike adult glioma, includes expression on lower-grade tumors.
Original languageEnglish
Pages (from-to)6919-6924
Number of pages6
JournalAnticancer Research
Issue number12
Publication statusPublished - 1 Dec 2014


  • brain tumors
  • NG2
  • paediatric


Dive into the research topics of 'Expression of the chondroitin sulphate proteoglycan, NG2, in paediatric brain tumors'. Together they form a unique fingerprint.

Cite this